Literature DB >> 16773412

Urinary neutrophil gelatinase-associated lipocalcin in D+HUS: a novel marker of renal injury.

Howard Trachtman1, Erica Christen, Avital Cnaan, Jilma Patrick, Volker Mai, Jaya Mishra, Aditya Jain, Nathan Bullington, Prasad Devarajan.   

Abstract

BACKGROUND: Diarrhea-associated hemolytic uremic syndrome (D+HUS) causes acute renal failure. Neutrophil gelatinase-associated lipocalcin (NGAL) is an early indicator of kidney injury.
OBJECTIVE: To determine if urinary NGAL excretion is a biomarker of severe renal injury and predicts the need for dialysis in D+HUS.
METHODS: Patients were randomly selected from among participants in the SYNSORB Pk trial. Urine samples were collected daily if available during the first week of hospitalization. NGAL levels were determined by ELISA.
RESULTS: 34 children, age 5.9+/-3.9 yr, were studied; ten (29%) required dialysis. Patients were categorized based on urinary NGAL concentration within five days of hospitalization - <200 ng/ml and >or=200 ng/ml. Twenty patients (58%) had increased urinary NGAL excretion. The severity of D+HUS at enrollment was similar in the two groups. However, children with increased urinary NGAL levels had higher peak BUN and creatinine concentrations (P<0.01) and required dialysis more often, 9/20 versus 1/14 (P=0.024) compared to children with normal excretion.
CONCLUSION: The majority of patients with D+HUS have renal tubular epithelial injury, as evidenced by elevated urinary NGAL excretion. Urinary NGAL levels below 200 ng/ml within five days of hospitalization may be an adjunctive marker that defines less severe renal involvement.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16773412     DOI: 10.1007/s00467-006-0146-y

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  20 in total

1.  Hemolytic uremic syndrome: epidemiology, pathophysiology, and therapy.

Authors:  Sharon P Andreoli; Howard Trachtman; David W K Acheson; Richard L Siegler; Tom G Obrig
Journal:  Pediatr Nephrol       Date:  2002-04       Impact factor: 3.714

2.  Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery.

Authors:  Jaya Mishra; Catherine Dent; Ridwan Tarabishi; Mark M Mitsnefes; Qing Ma; Caitlin Kelly; Stacey M Ruff; Kamyar Zahedi; Mingyuan Shao; Judy Bean; Kiyoshi Mori; Jonathan Barasch; Prasad Devarajan
Journal:  Lancet       Date:  2005 Apr 2-8       Impact factor: 79.321

Review 3.  The pathogenesis and treatment of hemolytic uremic syndrome.

Authors:  B S Kaplan; K E Meyers; S L Schulman
Journal:  J Am Soc Nephrol       Date:  1998-06       Impact factor: 10.121

4.  Management of patients with hemolytic uremic syndrome demonstrating severe azotemia but not anuria.

Authors:  S L Schulman; B S Kaplan
Journal:  Pediatr Nephrol       Date:  1996-10       Impact factor: 3.714

Review 5.  Spectrum of extrarenal involvement in postdiarrheal hemolytic-uremic syndrome.

Authors:  R L Siegler
Journal:  J Pediatr       Date:  1994-10       Impact factor: 4.406

6.  Up-regulation of tissue factor activity on human proximal tubular epithelial cells in response to Shiga toxin.

Authors:  Eirini Nestoridi; Rafail I Kushak; Dayana Duguerre; Eric F Grabowski; Julie R Ingelfinger
Journal:  Kidney Int       Date:  2005-06       Impact factor: 10.612

Review 7.  Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome.

Authors:  Phillip I Tarr; Carrie A Gordon; Wayne L Chandler
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

8.  Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin.

Authors:  Jaya Mishra; Kiyoshi Mori; Qing Ma; Caitlin Kelly; Jun Yang; Mark Mitsnefes; Jonathan Barasch; Prasad Devarajan
Journal:  J Am Soc Nephrol       Date:  2004-12       Impact factor: 10.121

Review 9.  Pathogenesis, treatment, and therapeutic trials in hemolytic uremic syndrome.

Authors:  H Trachtman; E Christen
Journal:  Curr Opin Pediatr       Date:  1999-04       Impact factor: 2.856

10.  Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: a randomized controlled trial.

Authors:  Howard Trachtman; Avital Cnaan; Erica Christen; Kathleen Gibbs; Sanyi Zhao; David W K Acheson; Robert Weiss; Frederick J Kaskel; Adrian Spitzer; Gladys H Hirschman
Journal:  JAMA       Date:  2003-09-10       Impact factor: 56.272

View more
  70 in total

1.  Neutrophil gelatinase-associated lipocalin is instrumental in the pathogenesis of antibody-mediated nephritis in mice.

Authors:  Rahul D Pawar; Milena Pitashny; Simona Gindea; Arlene Tan Tieng; Benjamin Levine; Beatrice Goilav; Sean R Campbell; Yumin Xia; Xiaoping Qing; David B Thomas; Leal Herlitz; Thorsten Berger; Tak W Mak; Chaim Putterman
Journal:  Arthritis Rheum       Date:  2012-05

2.  Urinary vascular cell adhesion molecule, but not neutrophil gelatinase-associated lipocalin, is associated with lupus nephritis.

Authors:  Adnan N Kiani; Tianfu Wu; Hong Fang; Xin J Zhou; Chul W Ahn; Laurence S Magder; Chandra Mohan; Michelle Petri
Journal:  J Rheumatol       Date:  2012-04-15       Impact factor: 4.666

3.  Role of circulating fibroblast growth factor-2 in lipopolysaccharide-induced acute kidney injury in mice.

Authors:  Parnell C Mattison; Angel A Soler-García; Jharna R Das; Marina Jerebtsova; Sofia Perazzo; Pingtao Tang; Patricio E Ray
Journal:  Pediatr Nephrol       Date:  2011-09-30       Impact factor: 3.714

4.  Emerging urinary biomarkers in the diagnosis of acute kidney injury.

Authors:  Prasad Devarajan
Journal:  Expert Opin Med Diagn       Date:  2008-04

5.  NGAL is an early predictive biomarker of contrast-induced nephropathy in children.

Authors:  Russel Hirsch; Catherine Dent; Holly Pfriem; Janene Allen; Robert H Beekman; Qing Ma; Sudha Dastrala; Michael Bennett; Mark Mitsnefes; Prasad Devarajan
Journal:  Pediatr Nephrol       Date:  2007-09-14       Impact factor: 3.714

Review 6.  The importance of total kidney volume in evaluating progression of polycystic kidney disease.

Authors:  Jared J Grantham; Vicente E Torres
Journal:  Nat Rev Nephrol       Date:  2016-10-03       Impact factor: 28.314

7.  Roles of neutrophil gelatinase-associated lipocalin in continuous ambulatory peritoneal dialysis-related peritonitis.

Authors:  Joseph C K Leung; Man Fai Lam; Sydney C W Tang; Loretta Y Y Chan; K Y Tam; Terence P S Yip; Kar Neng Lai
Journal:  J Clin Immunol       Date:  2009-01-16       Impact factor: 8.317

Review 8.  Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of kidney disease.

Authors:  Prasad Devarajan
Journal:  Scand J Clin Lab Invest Suppl       Date:  2008

Review 9.  Progression from acute kidney injury to chronic kidney disease: a pediatric perspective.

Authors:  Stuart L Goldstein; Prasad Devarajan
Journal:  Adv Chronic Kidney Dis       Date:  2008-07       Impact factor: 3.620

Review 10.  Biomarkers of acute kidney injury.

Authors:  Charles L Edelstein
Journal:  Adv Chronic Kidney Dis       Date:  2008-07       Impact factor: 3.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.